Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenin expression in superficial bladder cancer.

K Maeda1, K Nomata, M Noguchi

  • 1Department of Urology, Nagasaki University School of Medicine.

Hinyokika Kiyo. Acta Urologica Japonica
|October 3, 2001
PubMed
Summary

Superficial bladder cancer exhibits lower angiogenin concentration in tumor tissues compared to normal tissues. This suggests a distinct role for angiogenin in bladder cancer development, differing from other angiogenic factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenoid cystic carcinoma of Cowper's gland.

BJU international·2009
Same author

Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients.

Prostate cancer and prostatic diseases·2007
Same author

Kidney transplantation from non-heart-beating donors: analysis of organ procurement and outcome.

Transplantation proceedings·2004
Same author

Clinicopathological study of vesicoureteral reflux (VUR)-associated pyelonephritis in renal transplantation.

Clinical transplantation·2004
Same author

Different clinicopathological courses of two recipients of kidneys retrieved from the same non-heart beating donor.

Clinical transplantation·2004
Same author

Adrenocortical carcinoma with primary aldosteronism associated with Cushing syndrome during recurrence.

BJU international·2002

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Angiogenin is a key angiogenic factor implicated in various cancers.
  • Its role in superficial bladder cancer remains incompletely understood.
  • Understanding angiogenin's expression is crucial for bladder cancer research.

Purpose of the Study:

  • To quantify angiogenin concentration in superficial bladder cancer tissues versus normal tissues.
  • To investigate the cellular localization of angiogenin expression in bladder cancer.
  • To explore the potential role of angiogenin in bladder cancer development.

Main Methods:

  • Sandwich enzyme immunoassay (ELISA) for quantifying angiogenin levels.
  • Immunohistochemical assays for determining angiogenin localization.

Related Experiment Videos

  • Comparative analysis between tumor and adjacent normal tissues from 20 patients.

    • Main Results:

    • Significantly lower mean angiogenin concentration in bladder carcinoma tissues compared to normal tissues (P < 0.001).
    • Weak angiogenin expression observed within bladder cancer cells.
    • Demonstrated reduced angiogenin expression in superficial bladder cancer.

    Conclusions:

    • Angiogenin expression is downregulated in superficial bladder cancer.
    • The biological function of angiogenin in bladder cancer carcinogenesis may differ from other angiogenic factors.
    • Further research is warranted to elucidate angiogenin's specific role in bladder tumorigenesis.